203 related articles for article (PubMed ID: 32345238)
1. The first study of successful pregnancies in Chinese patients with Phenylketonuria.
Wang L; Ye F; Zou H; Wang K; Chen Z; Hui Q; Han B; He C; Li X; Shen M
BMC Pregnancy Childbirth; 2020 Apr; 20(1):253. PubMed ID: 32345238
[TBL] [Abstract][Full Text] [Related]
2. Sapropterin dihydrochloride use in pregnant women with phenylketonuria: an interim report of the PKU MOMS sub-registry.
Grange DK; Hillman RE; Burton BK; Yano S; Vockley J; Fong CT; Hunt J; Mahoney JJ; Cohen-Pfeffer JL; ;
Mol Genet Metab; 2014 May; 112(1):9-16. PubMed ID: 24667082
[TBL] [Abstract][Full Text] [Related]
3. Use of sapropterin dihydrochloride in maternal phenylketonuria. A European experience of eight cases.
Feillet F; Muntau AC; Debray FG; Lotz-Havla AS; Puchwein-Schwepcke A; Fofou-Caillierez MB; van Spronsen F; Trefz FF
J Inherit Metab Dis; 2014 Sep; 37(5):753-62. PubMed ID: 24789341
[TBL] [Abstract][Full Text] [Related]
4. [Singleton and twin pregnancies of PKU patients - individual variability of phenylalanine tolerance: experience of a single treatment center (Preliminary report)].
Żółkowska J; Hozyasz KK; Nowacka M
Dev Period Med; 2017; 21(4):344-360. PubMed ID: 29291362
[TBL] [Abstract][Full Text] [Related]
5. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
Trefz FK; Blau N
Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
[TBL] [Abstract][Full Text] [Related]
6. Tetrahydrobiopterin and maternal PKU.
Koch R; Moseley K; Guttler F
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S139-41. PubMed ID: 16338627
[TBL] [Abstract][Full Text] [Related]
7. Role of nutrition in pregnancy with phenylketonuria and birth defects.
Matalon KM; Acosta PB; Azen C
Pediatrics; 2003 Dec; 112(6 Pt 2):1534-6. PubMed ID: 14654660
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine.
Maillot F; Lilburn M; Baudin J; Morley DW; Lee PJ
Am J Clin Nutr; 2008 Sep; 88(3):700-5. PubMed ID: 18779286
[TBL] [Abstract][Full Text] [Related]
9. [The maternal phenylketonuria syndrom--still current problem].
Didycz B; Domagała L; Pietrzyk JJ
Przegl Lek; 2009; 66(1-2):4-10. PubMed ID: 19485248
[TBL] [Abstract][Full Text] [Related]
10. International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria.
Muntau AC; Adams DJ; Bélanger-Quintana A; Bushueva TV; Cerone R; Chien YH; Chiesa A; Coşkun T; de Las Heras J; Feillet F; Katz R; Lagler F; Piazzon F; Rohr F; van Spronsen FJ; Vargas P; Wilcox G; Bhattacharya K
Mol Genet Metab; 2019 May; 127(1):1-11. PubMed ID: 31103398
[TBL] [Abstract][Full Text] [Related]
11. Maternal phenylketonuria: low phenylalaninemia might increase the risk of intra uterine growth retardation.
Teissier R; Nowak E; Assoun M; Mention K; Cano A; Fouilhoux A; Feillet F; Ogier H; Oger E; de Parscau L;
J Inherit Metab Dis; 2012 Nov; 35(6):993-9. PubMed ID: 22669364
[TBL] [Abstract][Full Text] [Related]
12. Maternal Phenylketonuria Collaborative Study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelae.
Rouse B; Azen C; Koch R; Matalon R; Hanley W; de la Cruz F; Trefz F; Friedman E; Shifrin H
Am J Med Genet; 1997 Mar; 69(1):89-95. PubMed ID: 9066890
[TBL] [Abstract][Full Text] [Related]
13. Partial hydatidiform mole in a phenylketonuria patient treated with sapropterin dihydrochloride.
Yildiz Y; Dursun A; Tokatli A; Coskun T; Sivri S
Gynecol Endocrinol; 2017 Jan; 33(1):19-20. PubMed ID: 27898272
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
[TBL] [Abstract][Full Text] [Related]
15. Nutrition and reproductive outcome in maternal phenylketonuria.
Michals K; Acosta PB; Austin V; Castiglioni L; Rohr F; Wenz E; Azen C
Eur J Pediatr; 1996 Jul; 155 Suppl 1():S165-8. PubMed ID: 8828637
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations.
Kanufre V; Almeida MF; Barbosa CS; Carmona C; Bandeira A; Martins E; Rocha S; Guimas A; Ribeiro R; MacDonald A; Pinto A; Rocha JC
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578995
[TBL] [Abstract][Full Text] [Related]
17. Maternal phenylketonuria and hyperphenylalaninemia in pregnancy: pregnancy complications and neonatal sequelae in untreated and treated pregnancies.
Prick BW; Hop WC; Duvekot JJ
Am J Clin Nutr; 2012 Feb; 95(2):374-82. PubMed ID: 22205310
[TBL] [Abstract][Full Text] [Related]
18. A new case of maternal phenylketonuria treated with sapropterin dihydrochloride (6R-BH4).
Aldámiz-Echevarría L; Couce ML; Llarena M; Andrade F
Gynecol Endocrinol; 2014 Oct; 30(10):691-3. PubMed ID: 24927077
[TBL] [Abstract][Full Text] [Related]
19. The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study.
Burton BK; Grange DK; Milanowski A; Vockley G; Feillet F; Crombez EA; Abadie V; Harding CO; Cederbaum S; Dobbelaere D; Smith A; Dorenbaum A
J Inherit Metab Dis; 2007 Oct; 30(5):700-7. PubMed ID: 17846916
[TBL] [Abstract][Full Text] [Related]
20. Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias.
Blau N
Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1207-18. PubMed ID: 23705856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
